Loading clinical trials...
Loading clinical trials...
VRC 705: A Phase 2/2B, Randomized Trial to Evaluate the Safety, Immunogenicity and Efficacy of a Zika Virus DNA Vaccine in Healthy Adults and Adolescents
Conditions
Interventions
VRC-ZKADNA090-00-VP
VRC-PBSPLA043-00-VP
Locations
17
United States
QPS-Miami Research Associates
Miami, Florida, United States
Doctors Hospital at Renaissance
Edinburg, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
Hospital Das Clinicas Da Universidade Federal de Minas Gerais
Belo Horizonte, Minas Gerais, Brazil
Centro de Pesquisas Clínicas Do Instituto Central Do Hospital Das Clínicas Da FMUSP
São Paulo, São Paulo, Brazil
Clinica de la Costa Ltda
Barranquilla, Atlántico, Colombia
Start Date
March 29, 2017
Primary Completion Date
October 4, 2019
Completion Date
October 4, 2019
Last Updated
January 31, 2024
NCT04772469
NCT04064905
NCT06113757
NCT03624946
NCT05321433
NCT06205966
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions